publication venue for Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes.. 23:3794-3801. 2017 A novel HSP90 inhibitor-drug conjugate to SN38 is highly effective in small cell lung cancer (SCLC).. :-. 2016 Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens.. 21:3041-3051. 2015 A novel pharmacologic activity of ketorolac for therapeutic benefit in ovarian cancer patients.. :-. 2015 Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein.. 21:2359-2366. 2015 A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma (mRCC.. :-. 2015 Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer.. 20:1856-1864. 2014 Platinum-based chemotherapy for variant castrate-resistant prostate cancer.. 19:3621-3630. 2013 Inhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78.. 19:2107-2116. 2013 Validation of a radiosensitivity molecular signature in breast cancer.. 18:5134-5143. 2012 Expression and functional significance of HtrA1 loss in endometrial cancer.. 17:427-436. 2011 Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer.. 16:1812-1823. 2010 Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses.. 13:4840-4848. 2007 Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma.. 12:6133-6143. 2006 Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression.. 12:20-28. 2006 Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer.. 12:878-887. 2006 Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.. 12:11-19. 2006 The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas.. 17:2014-2023.